tiprankstipranks
Nova Eye Medical (AU:EYE)
ASX:EYE
Australian Market
Holding AU:EYE?
Track your performance easily

Nova Eye Medical (EYE) Share Forecast & Price Target

10 Followers
See the Price Targets and Ratings of:

EYE Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Nova
Eye Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EYE Stock 12 Month Forecast

There Are No Analyst Ratings for AU:EYE In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

EYE Financial Forecast

EYE Earnings Forecast

Next quarter’s earnings estimate for EYE is >-AU$0.01 with a range of >-AU$0.01 to >-AU$0.01. The previous quarter’s EPS was -AU$0.01. EYE beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.00% of the time in the same period. In the last calendar year EYE has Preformed in-line its overall industry.
Next quarter’s earnings estimate for EYE is >-AU$0.01 with a range of >-AU$0.01 to >-AU$0.01. The previous quarter’s EPS was -AU$0.01. EYE beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.00% of the time in the same period. In the last calendar year EYE has Preformed in-line its overall industry.

EYE Sales Forecast

Next quarter’s sales forecast for EYE is AU$14.40M with a range of AU$14.40M to AU$14.40M. The previous quarter’s sales results were AU$13.19M. EYE beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year EYE has Preformed in-line its overall industry.
Next quarter’s sales forecast for EYE is AU$14.40M with a range of AU$14.40M to AU$14.40M. The previous quarter’s sales results were AU$13.19M. EYE beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year EYE has Preformed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

EYE Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

EYE Stock Forecast FAQ

What is AU:EYE’s average 12-month price target, according to analysts?
Currently, no data Available
What is AU:EYE’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AU:EYE, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Nova Eye Medical a Buy, Sell or Hold?
      Currently, no data Available
      What is Nova Eye Medical’s share price target?
      Currently, no data Available
      What do analysts say about Nova Eye Medical?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Nova Eye Medical?
      To buy shares of AU:EYE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis